"The U.S. Food and Drug Administration today announced that it has approved an amended application submitted by Teva Women's Health, Inc. to market Plan B One-Step (active ingredient levonorgestrel) for use without a prescription by women 15 years"...
The use of Depo-Provera CI is contraindicated in the following conditions:
- Known or suspected pregnancy or as a diagnostic test for pregnancy.
- Active thrombophlebitis, or current or past history of thromboembolic disorders, or cerebral vascular disease [see WARNINGS AND PRECAUTIONS].
- Known or suspected malignancy of breast [see WARNINGS AND PRECAUTIONS].
- Known hypersensitivity to Depo-Provera CI (medroxyprogesterone acetate) or any of its other ingredients [see WARNINGS AND PRECAUTIONS].
- Significant liver disease [see WARNINGS AND PRECAUTIONS].
- Undiagnosed vaginal bleeding [see WARNINGS AND PRECAUTIONS].
Last reviewed on RxList: 8/31/2011
This monograph has been modified to include the generic and brand name in many instances.
Additional Depo Provera Information
Depo Provera - User Reviews
Depo Provera User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.